Mingxi Hua
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 3
- Journals
- Microbes and Infection (2 papers)Microbiology Spectrum (2 papers)Virulence (1 paper)Cell Reports (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Mingxi Hua
19 papers receiving 224 citations
Peers
Comparison fields: 5 of 70
- Applied Microbiology and Biotechnology 26
- Molecular Medicine 37
- Endocrinology 31
- Critical Care and Intensive Care Medicine 19
- Infectious Diseases 66
Countries citing papers authored by Mingxi Hua
This map shows the geographic impact of Mingxi Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxi Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxi Hua more than expected).
Fields of papers citing papers by Mingxi Hua
This network shows the impact of papers produced by Mingxi Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxi Hua. The network helps show where Mingxi Hua may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingxi Hua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 14 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 70 | |
| 13 | 2021 | 47 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 1 | |
| 16 | 2020 | 2 | |
| 17 | 2018 | 1 | |
| 18 | 2013 | 29 | |
| 19 | 2012 | 10 |
About Mingxi Hua
Mingxi Hua is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Endocrinology, Infectious Diseases and Microbiology, having authored 19 papers that have together received 228 indexed citations. Recurring topics across this work include Gut microbiota and health (4 papers), Antibiotic Resistance in Bacteria (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Respiratory viral infections research (2 papers), Mesenchymal stem cell research (2 papers), Vibrio bacteria research studies (2 papers), Liver physiology and pathology (2 papers) and Immune responses and vaccinations (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (26 citations), Molecular Medicine (37 citations), Endocrinology (31 citations), Critical Care and Intensive Care Medicine (19 citations) and Infectious Diseases (66 citations). Mingxi Hua has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jingyuan Liu, Siyuan Yang, Lin Pu, Linghang Wang, Xiang Pan, Xueyang Li, Haiyan Zhang, Xin Lü, Weihong Li and Chuan Song. Their work appears in journals such as Microbes and Infection, Microbiology Spectrum, Virulence, Cell Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.